Adnavance Technologies develops direct detection molecular diagnostic tests for medical applications.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: San Diego
State: California
Zip:
Country: United States
Adnavance Technologies is an early-stage developer of direct detection molecular diagnostic tests. The company&s;s patented and ultra-sensitive metalized-DNA (M-DNAâ„¢) technology may eliminate the need for amplification for a large number of these tests. This technology provides many significant advantages over existing methods, including ease of use, time to result and cost. The platform is simple and inexpensive and is expected to receive FDA approval for use by any laboratory.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2008 | Series B | 3 | $3.8M |
BDC Venture Capital GrowthWorks Capital JovFunds BDC Venture Capital GrowthWorks Capital JovFunds |
11/2005 | Series A | 3 | $3.9M |
Business Development Bank of Canada GrowthWorks Capital MDS Capital Business Development Bank of Canada GrowthWorks Capital MDS Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|